Irix Pharmaceuticals

Irix Pharmaceuticals is a research-driven company based in Florence, SC, specializing in the development of innovative pharmaceutical products. With a focus on cutting-edge technology and scientific expertise, Irix Pharmaceuticals is dedicated to advancing healthcare solutions for a variety of medical needs. Generated from their business information

Roche Carolina was incorporated in 1992 and has been focused on helping its parent company, Hoffmann-La Roche, get its medicines to market faster and more efficiently. Roche Carolina is a division of Hoffman-La Roche s pharmaceutical sector. Hoffmann-La Roche consists of a family of companies with more than 20 pharmaceutical research and production facilities worldwide. Roche Carolina is one of the four Roche Pharmaceutical research and development/production facilities in the United States. Its workforce consists of more than 300 employees, of which 65 percent are college educated. Roche Carolina is headquartered at the crossroads of CSC Railway, Interstate 20 and Interstate 95 in Florence, S.C.

IRIX Pharmaceuticals is engaged in the generation of process technology for new and existing drugs. It offers the capability of supplying API s and complex pharma intermediates from preclinical stages, through all phases of clinical trials, registration and validation batches and launch and commercial quantities. The company was formed to provide the pharmaceutical industry with a low-cost alternative for bringing new drugs to market rapidly. IRIX Pharmaceuticals operates three sites for process research and development and clinical and commercial cGMP production of APIs. Process research and development and early stage clinical supply for APIs is based in Florence, S.C., and late-stage clinical supply and commercial production is located at the company's facility in Greenville, S.C. The company supports new drug development in all functions necessary to bring a pharmaceutical candidate from discovery to market.